| First Author | Wang Q | Year | 2020 |
| Journal | Front Immunol | Volume | 11 |
| Pages | 846 | PubMed ID | 32528465 |
| Mgi Jnum | J:308191 | Mgi Id | MGI:6705687 |
| Doi | 10.3389/fimmu.2020.00846 | Citation | Wang Q, et al. (2020) Perforin Acts as an Immune Regulator to Prevent the Progression of NAFLD. Front Immunol 11:846 |
| abstractText | Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of cirrhosis and major risk factors for hepatocellular carcinoma and liver-related death. Despite substantial clinical and basic research, the pathogenesis of obesity-related NAFLD remains poorly understood. In this study, we show that perforin can act as an immune regulator to prevent the progression of NAFLD. Aged perforin-deficient (Prf(-/-)) mice have increased lipid accumulation in the liver compared to WT mice. With high-fat diet (HFD) challenge, Prf(-/-) mice have increased liver weight, more severe liver damage, and increased liver inflammation when compared with WT controls. Mechanistic studies revealed that perforin specifically regulates intrinsic IFN-gamma production in CD4 T cells, not CD8 T cells. We found that CD4 T cell depletion reduces liver injury and ameliorates the inflammation and metabolic morbidities in Prf(-/-) mice. Furthermore, improved liver characteristics in HFD Prf(-/-) and IFN-gammaR(-/-) double knockout mice confirmed that IFN-gamma is a key factor for mediating perforin regulation of NAFLD progression. Overall, our findings reveal the important regulatory role perforin plays in the progression of obesity-related NAFLD and highlight novel strategies for treating NAFLD. |
